BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-80. [DOI: 10.1038/nrgastro.2013.50] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Naik RD, Evers L, Vaezi MF. Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease. Curr Treat Options Gastro 2019;17:1-17. [DOI: 10.1007/s11938-019-00213-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, Sakaguchi Y, Nakayama C, Konno-Shimizu M, Matsuda R, Mochizuki S, Asada-Hirayama I, Tsuji Y, Kodashima S, Ono S, Niimi K, Mitsushima T, Koike K. Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One. 2013;8:e69891. [PMID: 23922844 DOI: 10.1371/journal.pone.0069891] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
3 Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 2019;15:1081-93. [PMID: 31564886 DOI: 10.2147/TCRM.S184291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Savarino V, Tosetti C, Benedetto E, Compare D, Nardone G. Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) - Study section "Digestive Diseases in Primary Care". Dig Liver Dis 2018;50:894-902. [PMID: 30093304 DOI: 10.1016/j.dld.2018.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
5 Zhang MY, Tan ND, Li YW, Sifrim D, Pandolfino JE, Xiao YL, Chen MH. Esophageal symptoms versus epigastric symptoms: Relevance for diagnosis of gastroesophageal reflux disease. J Dig Dis 2020;21:696-704. [PMID: 32975045 DOI: 10.1111/1751-2980.12946] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Choi JM, Yang JI, Kang SJ, Han YM, Lee J, Lee C, Chung SJ, Yoon DH, Park B, Kim YS. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. J Neurogastroenterol Motil 2018;24:593-602. [PMID: 30347938 DOI: 10.5056/jnm18069] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
7 Ottonello A, Savarino V, Savarino E. Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig 2013;17:1965-6. [PMID: 23929362 DOI: 10.1007/s00784-013-1071-7] [Reference Citation Analysis]
8 Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Des Devel Ther 2021;15:1609-21. [PMID: 33907381 DOI: 10.2147/DDDT.S306371] [Reference Citation Analysis]
9 Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology. 2016;150:1368-1379. [PMID: 27144625 DOI: 10.1053/j.gastro.2016.02.012] [Cited by in Crossref: 254] [Cited by in F6Publishing: 133] [Article Influence: 42.3] [Reference Citation Analysis]
10 Lee SW, Chang CS. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:176-84. [PMID: 33795540 DOI: 10.5056/jnm19006] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hachem C, Shaheen NJ. Diagnosis and Management of Functional Heartburn. Am J Gastroenterol 2016;111:53-61; quiz 62. [PMID: 26729546 DOI: 10.1038/ajg.2015.376] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
12 Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, Mirante VG, Bertani H, Marchi S, Conigliaro R, Savarino V. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease. Clinical Gastroenterology and Hepatology 2016;14:40-6. [DOI: 10.1016/j.cgh.2015.06.026] [Cited by in Crossref: 163] [Cited by in F6Publishing: 134] [Article Influence: 27.2] [Reference Citation Analysis]
13 de Bortoli N, Guidi G, Martinucci I, Savarino E, Imam H, Bertani L, Russo S, Franchi R, Macchia L, Furnari M. Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study. Dis Esophagus. 2016;29:197-204. [PMID: 25516110 DOI: 10.1111/dote.12319] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
14 Tolone S, De Bortoli N, Marabotto E, de Cassan C, Bodini G, Roman S, Furnari M, Savarino V, Docimo L, Savarino E. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterol Motil. 2015;27:1423-1431. [PMID: 26227513 DOI: 10.1111/nmo.12638] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
15 Luo X, Guo XX, Wang WF, Peng LH, Yang YS, Uedo N. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. World J Gastroenterol 2016; 22(14): 3845-3851 [PMID: 27076770 DOI: 10.3748/wjg.v22.i14.3845] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Savarino E, Zentilin P, Furnari M, Bodini G, Marabotto E, Savarino V. Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. J Neurogastroenterol Motil 2014;20:129-30. [PMID: 24466456 DOI: 10.5056/jnm.2014.20.1.129] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Sobrino-Cossío S, Soto-Pérez JC, Coss-Adame E, Mateos-Pérez G, Teramoto Matsubara O, Tawil J, Vallejo-Soto M, Sáez-Ríos A, Vargas-Romero JA, Zárate-Guzmán AM, Galvis-García ES, Morales-Arámbula M, Quiroz-Castro O, Carrasco-Rojas A, Remes-Troche JM. Post-fundoplication symptoms and complications: Diagnostic approach and treatment. Rev Gastroenterol Mex 2017;82:234-47. [PMID: 28065591 DOI: 10.1016/j.rgmx.2016.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
18 Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179. [PMID: 27825371 DOI: 10.1186/s12916-016-0718-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 24.7] [Reference Citation Analysis]
19 Jiang Y, Jiang L, Ye B, Lin L. Value of adjunctive evidence from MII-pH monitoring and high-resolution manometry in inconclusive GERD patients with AET 4-6. Therap Adv Gastroenterol 2021;14:17562848211013484. [PMID: 34104208 DOI: 10.1177/17562848211013484] [Reference Citation Analysis]
20 de Bortoli N, Martinucci I, Savarino EV, Frazzoni M, Tutuian R, Tolone S, Piaggi P, Furnari M, Russo S, Bertani L, Macchia L, Savarino V, Marchi S. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. Dig Liver Dis 2015;47:1027-32. [PMID: 26362613 DOI: 10.1016/j.dld.2015.08.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Wong MW, Hung JS, Liu TT, Yi CH, Lei WY, Liang SW, Orr WC, Chen CL. Esophageal acid burden in reflux patients with normal endoscopy: Does esophageal peristalsis matter? J Formos Med Assoc 2021:S0929-6646(21)00236-9. [PMID: 34090788 DOI: 10.1016/j.jfma.2021.05.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hungin APS, Scarpignato C, Keefer L, Corsetti M, Anastasiou F, Muris JWM, Mendive JM, Kahrilas PJ. Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective. Aliment Pharmacol Ther 2022;55:1492-500. [PMID: 35460095 DOI: 10.1111/apt.16930] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Pellegatta G, Coppo C, Savarino E. The appropriate use of proton-pump inhibitors. Minerva Med 2018;109. [DOI: 10.23736/s0026-4806.18.05705-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 5.8] [Reference Citation Analysis]
24 Martinucci I, Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 2014; 5(2): 86-96 [PMID: 24868489 DOI: 10.4292/wjgpt.v5.i2.86] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
25 Sobrino-cossío S, Teramoto-matsubara O, Mateos-pérez G, Abdo-francis J, Tawil J, Olguín-ramírez C, Orozco-gamiz A, Galvis-garcía E. In search of the grail: A race for acid suppression. Revista de Gastroenterología de México (English Edition) 2019;84:344-56. [DOI: 10.1016/j.rgmxen.2019.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Frazzoni M, de Bortoli N, Frazzoni L, Furnari M, Martinucci I, Tolone S, Farioli A, Marchi S, Fuccio L, Savarino V, Savarino E. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol 2017;52:444-51. [PMID: 27241210 DOI: 10.1007/s00535-016-1226-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 11.8] [Reference Citation Analysis]
27 de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
28 Kandulski A, Moleda L, Müller-Schilling M. Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test? Visc Med 2018;34:97-100. [PMID: 29888237 DOI: 10.1159/000488184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Russo M, Miraglia C, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Approach to gastroenterological diseases in primary care. Acta Biomed 2018;89:5-11. [PMID: 30561411 DOI: 10.23750/abm.v89i8-S.7973] [Reference Citation Analysis]
30 Coyle C, Crawford G, Wilkinson J, Thomas SJ, Bytzer P. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Aliment Pharmacol Ther 2017;45:1524-33. [DOI: 10.1111/apt.14064] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
31 Cheng FK, Albert DM, Maydonovitch CL, Wong RK, Moawad FJ. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy. Clin Gastroenterol Hepatol 2015;13:867-73. [PMID: 25445765 DOI: 10.1016/j.cgh.2014.10.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
32 Lei WY, Vaezi MF, Naik RD, Chen CL. Mucosal impedance testing: A new diagnostic testing in gastroesophageal reflux disease. J Formos Med Assoc 2020;119:1575-80. [PMID: 31542333 DOI: 10.1016/j.jfma.2019.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Visaggi P, Mariani L, Svizzero FB, Tarducci L, Sostilio A, Frazzoni M, Tolone S, Penagini R, Frazzoni L, Ceccarelli L, Savarino V, Bellini M, Gyawali PC, Savarino EV, de Bortoli N. Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease. Esophagus 2022. [PMID: 35768671 DOI: 10.1007/s10388-022-00933-6] [Reference Citation Analysis]
34 Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, Gupta S, Langendam M, Staiano A, Thapar N, Tipnis N, Tabbers M. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:516-554. [PMID: 29470322 DOI: 10.1097/mpg.0000000000001889] [Cited by in Crossref: 258] [Cited by in F6Publishing: 74] [Article Influence: 86.0] [Reference Citation Analysis]
35 Saracco M, Savarino V, Bodini G, Saracco GM, Pellicano R. Gastroesophageal reflux disease: key messages for clinicians. Minerva Gastroenterol (Torino) 2021;67:390-403. [PMID: 33103406 DOI: 10.23736/S1121-421X.20.02783-X] [Reference Citation Analysis]
36 Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, Savarino E. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn: . American Journal of Gastroenterology 2018;113:670-6. [DOI: 10.1038/s41395-018-0044-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
37 Wilkinson J, Wade A, Thomas SJ, Jenner B, Hodgkinson V, Coyle C. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate–antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease. European Journal of Gastroenterology & Hepatology 2019;31:86-93. [DOI: 10.1097/meg.0000000000001258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
38 Savarino E, Giacchino M, Savarino V. The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. Surg Endosc 2013;27:3503-4. [PMID: 23846361 DOI: 10.1007/s00464-013-3039-8] [Reference Citation Analysis]
39 Weijenborg PW, de Schepper HS, Smout AJ, Bredenoord AJ. Effects of antidepressants in patients with functional esophageal disorders or gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2015;13:251-259.e1. [PMID: 24997325 DOI: 10.1016/j.cgh.2014.06.025] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 7.6] [Reference Citation Analysis]
40 Lee SW, Lee TY, Lien HC, Yang SS, Yeh HZ, Chang CS. Characteristics of symptom presentation and risk factors in patients with erosive esophagitis and nonerosive reflux disease. Med Princ Pract 2014;23:460-4. [PMID: 25012767 DOI: 10.1159/000363661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
41 Bortoli N, Gyawali CP, Frazzoni M, Tolone S, Frazzoni L, Vichi E, Visaggi P, Bellini M, Marabotto E, Penagini R, Savarino V, Marchi S, Savarino EV. Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Savarino E, Marabotto E, Bartolo O, de Cassan C. Comment on "impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602]. Dig Liver Dis 2014;46:1052. [PMID: 25081845 DOI: 10.1016/j.dld.2014.06.012] [Reference Citation Analysis]
43 Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K, Ogasawara N, Sasaki M, Kaneko H, Kasugai K. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol 2015; 21(16): 5009-5016 [PMID: 25945016 DOI: 10.3748/wjg.v21.i16.5009] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
44 Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
45 Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Martinucci I, Fuccio L, Savarino V, Savarino E. Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum. Ann Gastroenterol 2018;31:1-7. [PMID: 29333061 DOI: 10.20524/aog.2017.0199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
46 Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther 2017;45:631-42. [PMID: 28116754 DOI: 10.1111/apt.13914] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
47 Fabisiak A, Bartoszek A, Talar M, Binienda A, Dziedziczak K, Krajewska JB, Mosińska P, Niewinna K, Tarasiuk A, Mokrowiecka A, Wierzchniewska-Ławska A, Małecka-Panas E, Salaga M, Fichna J. Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. J Clin Med 2020;9:E4111. [PMID: 33419235 DOI: 10.3390/jcm9124111] [Reference Citation Analysis]
48 Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017;62:1881-1889. [PMID: 28550489 DOI: 10.1007/s10620-017-4625-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
49 Ang D, Zheng Q, Shi L, Tack J. Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis. United European Gastroenterol J 2018;6:1294-306. [PMID: 30386602 DOI: 10.1177/2050640618772787] [Reference Citation Analysis]
50 Savarino E, Ottonello A, Tolone S, Bartolo O, Baeg MK, Farjah F, Kuribayashi S, Shetler KP, Lottrup C, Stein E. Novel insights into esophageal diagnostic procedures. Ann N Y Acad Sci 2016;1380:162-77. [PMID: 27681220 DOI: 10.1111/nyas.13255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Sweis R, Anggiansah A, Wong T, Brady G, Fox M. Assessment of esophageal dysfunction and symptoms during and after a standardized test meal: development and clinical validation of a new methodology utilizing high-resolution manometry. Neurogastroenterol Motil 2014;26:215-28. [PMID: 24238326 DOI: 10.1111/nmo.12252] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
52 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
53 Savarino E, de Bortoli N, Bellini M, Galeazzi F, Ribolsi M, Salvador R, Savarino V, Penagini R. Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement. Dig Liver Dis 2016;48:1124-35. [PMID: 27443492 DOI: 10.1016/j.dld.2016.06.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
54 Savarino V, Antonioli L, Fornai M, Marabotto E, Demarzo MG, Zingone F, Ghisa M, Barberio B, Zentilin P, Ribolsi M, Savarino E. An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders. Expert Rev Gastroenterol Hepatol 2021;:1-10. [PMID: 34550866 DOI: 10.1080/17474124.2021.1984878] [Reference Citation Analysis]
55 de Bortoli N, Martinucci I, Savarino E, Tutuian R, Frazzoni M, Piaggi P, Bertani L, Furnari M, Franchi R, Russo S, Bellini M, Savarino V, Marchi S. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082-8.e1. [PMID: 25499991 DOI: 10.1016/j.cgh.2014.11.035] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 11.6] [Reference Citation Analysis]
56 Ullal TV, Marks SL, Belafsky PC, Conklin JL, Pandolfino JE. A Comparative Assessment of the Diagnosis of Swallowing Impairment and Gastroesophageal Reflux in Canines and Humans. Front Vet Sci 2022;9:889331. [PMID: 35754550 DOI: 10.3389/fvets.2022.889331] [Reference Citation Analysis]
57 Xie P, Yan J, Ye L, Wang C, Li Y, Chen Y, Li G. Efficacy of different endoscopic treatments in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Surg Endosc 2021;35:1500-10. [PMID: 33650003 DOI: 10.1007/s00464-021-08386-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal. Eur J Intern Med 2017;37:19-24. [PMID: 27784575 DOI: 10.1016/j.ejim.2016.10.007] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 15.7] [Reference Citation Analysis]
59 Jiang Y, Dong Z, Wang J, Chen Y, Sun H, Xu S, Toyokawa T. Efficacy of Endoscopic Radiofrequency Ablation for Treatment of Reflux Hypersensitivity: A Study Based on Rome IV Criteria. Gastroenterology Research and Practice 2022;2022:1-8. [DOI: 10.1155/2022/4145810] [Reference Citation Analysis]
60 Ribolsi M, Savarino E, De Bortoli N, Balestrieri P, Furnari M, Martinucci I, Casale M, Greco F, Salvinelli F, Savarino V. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40:966-973. [PMID: 25109844 DOI: 10.1111/apt.12919] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
61 Savarino E, De Cassan C, Bodini G, Furnari M, de Bortoli N, Savarino V. The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol 2014;49:1362-3. [PMID: 24972668 DOI: 10.1007/s00535-014-0974-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Mahoney LB, Nurko S, Rosen R. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children. J Pediatr 2017;189:86-91. [PMID: 28711175 DOI: 10.1016/j.jpeds.2017.06.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
63 Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol 2013; 19(48): 9256-9270 [PMID: 24409053 DOI: 10.3748/wjg.v19.i48.9256] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 71] [Article Influence: 9.1] [Reference Citation Analysis]
64 Gao F, Gao Y, Chen X, Qian J, Zhang J. Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients. BMC Gastroenterol 2017;17:67. [PMID: 28535800 DOI: 10.1186/s12876-017-0624-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Savarino E, Furnari M, Bodini G, Savarino V. Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? Am J Gastroenterol 2016;111:1037-8. [PMID: 27356832 DOI: 10.1038/ajg.2016.135] [Reference Citation Analysis]
66 Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G. Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol 2014; 20(39): 14272-14279 [PMID: 25339814 DOI: 10.3748/wjg.v20.i39.14272] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
67 Gyawali CP, Azagury DE, Chan WW, Chandramohan SM, Clarke JO, Bortoli N, Figueredo E, Fox M, Jodorkovsky D, Lazarescu A, Malfertheiner P, Martinek J, Murayama KM, Penagini R, Savarino E, Shetler KP, Stein E, Tatum RP, Wu J. Nonerosive reflux disease: clinical concepts. Ann N Y Acad Sci 2018;1434:290-303. [DOI: 10.1111/nyas.13845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
68 Scarpignato C, Gatta L. Acid Suppression for Management of Gastroesophageal Reflux Disease: Benefits and Risks. In: Morice AH, Dettmar PW, editors. Reflux Aspiration and Lung Disease. Cham: Springer International Publishing; 2018. pp. 269-91. [DOI: 10.1007/978-3-319-90525-9_23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Marabotto E, Savarino V, Ghisa M, Frazzoni M, Ribolsi M, Barberio B, Savarino E. Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis. Current Opinion in Pharmacology 2022;65:102264. [DOI: 10.1016/j.coph.2022.102264] [Reference Citation Analysis]
70 Lorentzen J, Medhus AW, Hertel JK, Borgeraas H, Karlsen TI, Kolotkin RL, Sandbu R, Sifrim D, Svanevik M, Hofsø D, Seip B, Hjelmesæth J. Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study.Obes Surg. 2020;30:2667-2675. [PMID: 32193740 DOI: 10.1007/s11695-020-04545-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Ribolsi M, Balestrieri P, Holloway RH, Emerenziani S, Cicala M. Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate. Dis Esophagus 2016;29:1020-6. [PMID: 26542165 DOI: 10.1111/dote.12434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
72 Guo Z, Wu H, Jiang J, Zhang C. Pepsin in Saliva as a Diagnostic Marker for Gastroesophageal Reflux Disease: A Meta-Analysis. Med Sci Monit 2018;24:9509-16. [PMID: 30596632 DOI: 10.12659/MSM.913978] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
73 Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Pellegatta G, Coppo C, Savarino E. Proton pump inhibitors: use and misuse in the clinical setting. Expert Rev Clin Pharmacol 2018;11:1123-34. [PMID: 30295105 DOI: 10.1080/17512433.2018.1531703] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 11.5] [Reference Citation Analysis]
74 Scarpignato C, Hunt RH. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Current Opinion in Gastroenterology 2019;35:344-55. [DOI: 10.1097/mog.0000000000000543] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
75 Jain M, Agrawal V. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms. Indian J Gastroenterol 2020;39:165-70. [DOI: 10.1007/s12664-020-01032-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Viazis N, Karamanolis GP, Anastasiou J, Keyoglou A, Vlachogiannakos J, Ladas SD, Karamanolis DG. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn. Eur J Gastroenterol Hepatol 2013;25:1450-5. [PMID: 24047861 DOI: 10.1097/MEG.0b013e328365d2a8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
77 Nikaki K, Woodland P, Sifrim D. Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol. 2016;13:529-542. [PMID: 27485786 DOI: 10.1038/nrgastro.2016.109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
78 Tolone S, Savarino E, De Bortoli N, Docimo L. Sleeve Gastrectomy, GERD, and Barrett's Esophagus: It Is Time for Objective Testing. Obes Surg 2019;29:2312-3. [PMID: 31062277 DOI: 10.1007/s11695-019-03902-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
79 Furnari M, Tolone S, Savarino E. Caution About Overinterpretation of Number of Reflux Episodes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2016;14:1060. [DOI: 10.1016/j.cgh.2015.05.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Silva RO, Bingana RD, Sales TMAL, Moreira RLR, Costa DVS, Sales KMO, Brito GAC, Santos AA, Souza MÂN, Soares PMG, Sifrim D, Souza MHLP. Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease. Neurogastroenterol Motil 2018;30:e13340. [DOI: 10.1111/nmo.13340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
81 Savarino E, Frazzoni M, Marabotto E, Zentilin P, Iovino P, Costantini M, Tolone S, Battaglia E, Cicala M, Usai-satta P, de Bortoli N, Penagini R, Savarino V. A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring. Digestive and Liver Disease 2020;52:966-80. [DOI: 10.1016/j.dld.2020.04.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
82 Teragawa H, Oshita C, Ueda T. History of gastroesophageal reflux disease in patients with suspected coronary artery disease. Heart Vessels. 2019;34:1631-1638. [PMID: 30993440 DOI: 10.1007/s00380-019-01413-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
83 Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G;  European Association of Endoscopic Surgery (EAES). EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-1773. [PMID: 24789125 DOI: 10.1007/s00464-014-3431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
84 Martinucci I, de Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A, Savarino V, Frazzoni M, Marchi S. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26:546-555. [PMID: 24433456 DOI: 10.1111/nmo.12299] [Cited by in Crossref: 122] [Cited by in F6Publishing: 101] [Article Influence: 15.3] [Reference Citation Analysis]
85 Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2013;21:548-556. [PMID: 24240131 DOI: 10.1097/moo.0b013e3283658edf] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Furnari M, de Bortoli N, Savarino V, Marchi S, Savarino E. Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure. Surg Endosc. 2014;28:1382-1383. [PMID: 24162141 DOI: 10.1007/s00464-013-3291-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Tolone S, de Cassan C, de Bortoli N, Roman S, Galeazzi F, Salvador R, Marabotto E, Furnari M, Zentilin P, Marchi S, Bardini R, Sturniolo GC, Savarino V, Savarino E. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD. Neurogastroenterol Motil. 2015;27:1175-1182. [PMID: 26010058 DOI: 10.1111/nmo.12606] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
88 Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:453-81. [PMID: 34642267 DOI: 10.5056/jnm21077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
89 Savarino E, Coletta MD. Symptom perception in patients with NERD: do nerves matter? Nat Rev Gastroenterol Hepatol 2017;14:634-6. [DOI: 10.1038/nrgastro.2017.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
90 Scarpignato C, Sloan JA, Wang DH, Hunt RH. Gastrointestinal pharmacology: practical tips for the esophagologist. Ann N Y Acad Sci 2020;1481:90-107. [PMID: 32822080 DOI: 10.1111/nyas.14447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Suzuki T, Matsushima M, Masui A, Tsuda S, Imai J, Nakamura J, Tsukune Y, Uchida T, Yuhara H, Igarashi M, Koike J, Mine T. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. World J Gastroenterol 2015; 21(16): 5023-5031 [PMID: 25945018 DOI: 10.3748/wjg.v21.i16.5023] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
92 Savarino E, Ottonello A, Martinucci I, Dulbecco P, Savarino V. Ilaprazole for the treatment of gastro-esophageal reflux. Expert Opinion on Pharmacotherapy 2016;17:2107-13. [DOI: 10.1080/14656566.2016.1232389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
93 Savarino E, Marabotto E, Savarino V. Recent insights on functional heartburn and reflux hypersensitivity. Curr Opin Gastroenterol 2022;38:417-22. [PMID: 35762702 DOI: 10.1097/MOG.0000000000000846] [Reference Citation Analysis]
94 Savarino V, Marabotto E, Zentilin P, Demarzo MG, Pellegatta G, Frazzoni M, De Bortoli N, Tolone S, Giannini EG, Savarino E. Esophageal reflux hypersensitivity: Non-GERD or still GERD? Dig Liver Dis 2020;52:1413-20. [PMID: 33097427 DOI: 10.1016/j.dld.2020.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M, Bodini G, Russo S, Bertani L, Natali V, Fuccio L, Savarino V, Blandizzi C, Marchi S. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol 2016;111:1711-7. [PMID: 27644732 DOI: 10.1038/ajg.2016.432] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
96 Kondo T, Sei H, Yamasaki T, Tomita T, Ohda Y, Oshima T, Fukui H, Watari J, Miwa H. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 2017;52:1081-9. [DOI: 10.1007/s00535-017-1308-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
97 Akiyama J, Kuribayashi S, Baeg MK, Bortoli N, Valitova E, Savarino EV, Kusano M, Triadafilopoulos G. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci 2018;1434:70-83. [DOI: 10.1111/nyas.13850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Current treatment options for esophageal diseases. Ann N Y Acad Sci 2016;1381:139-51. [PMID: 27391867 DOI: 10.1111/nyas.13146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
99 Soto-Solís R, Santana-de Anda K, González-Uribe N, Gallegos C, Romo-Aguirre C, Remes-Troche JM, Ballesteros-Amozurrutia MA. How to improve the diagnosis of eosinophilic esophagitis: Experience from a case series in Mexico. Rev Gastroenterol Mex 2017;82:5-12. [PMID: 27712908 DOI: 10.1016/j.rgmx.2016.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
100 Niu CY, Zhou YS, Wu FX. Individualized medicine of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2018; 26(35): 2046-2056 [DOI: 10.11569/wcjd.v26.i35.2046] [Reference Citation Analysis]
101 Hungin APS, Molloy-Bland M, Scarpignato C. Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD. Am J Gastroenterol 2019;114:414-21. [PMID: 30323266 DOI: 10.1038/s41395-018-0287-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
102 Lee JY, Kim N, Park JH, Yu JE, Song YJ, Yoon JW, Lee DH. Sex and Gender Differences in Overlap Syndrome of Functional Gastrointestinal Disorder and Effect of Genetic Polymorphisms in South Korea: A Long-term Follow-up Study. J Neurogastroenterol Motil 2022;28:145-58. [PMID: 34980697 DOI: 10.5056/jnm21047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
103 de Bortoli N, Ottonello A, Zerbib F, Sifrim D, Gyawali CP, Savarino E. Between GERD and NERD: the relevance of weakly acidic reflux: Weakly acidic reflux in GERD. Ann N Y Acad Sci 2016;1380:218-29. [DOI: 10.1111/nyas.13169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
104 Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Furnari M, Martinucci I, Mirante VG, Marchi S, Savarino V, Savarino E. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil 2017;29. [PMID: 27620303 DOI: 10.1111/nmo.12947] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
105 Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, Bertani H, Marchi S, Conigliaro R, Fuccio L, Savarino V, Savarino E. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017;29. [PMID: 28543861 DOI: 10.1111/nmo.13116] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
106 Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018;67:1351-62. [PMID: 29437910 DOI: 10.1136/gutjnl-2017-314722] [Cited by in Crossref: 542] [Cited by in F6Publishing: 384] [Article Influence: 135.5] [Reference Citation Analysis]
107 Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP; International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol 2017;14:665-76. [PMID: 28951582 DOI: 10.1038/nrgastro.2017.130] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 23.2] [Reference Citation Analysis]
108 Kim JY, Shin IS, Min YW, Kim K, Lee H, Min BH, Lee JH, Kim JJ, Rhee PL. Endoscopic Prediction for Acid Reflux in Patients without Hiatus Hernia. Korean J Gastroenterol 2020;76:134-41. [PMID: 32969361 DOI: 10.4166/kjg.2020.76.3.134] [Reference Citation Analysis]
109 Song IJ, Kim HK, Lee NK, Lee SK. Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis. Yonsei Med J 2018;59:951-9. [PMID: 30187702 DOI: 10.3349/ymj.2018.59.8.951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Kim EJ, Lee OY, Lee KN, Lee SJ, Jang JY, Cho JW, Kim TO. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. J Neurogastroenterol Motil 2019;25:403-12. [PMID: 31327222 DOI: 10.5056/jnm18185] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Carabotti M, Esposito G, Lahner E, Pilozzi E, Conti L, Ranazzi G, Severi C, Bellini M, Annibale B. Gastroesophageal reflux symptoms and microscopic esophagitis in a cohort of consecutive patients affected by atrophic body gastritis: a pilot study. Scand J Gastroenterol 2019;54:35-40. [PMID: 30638085 DOI: 10.1080/00365521.2018.1553062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Zentilin P, Savarino V, Marabotto E, Murdaca G, Sulli A, Pizzorni C, Puppo F, Savarino E. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism 2018;47:569-74. [DOI: 10.1016/j.semarthrit.2017.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
113 de Bortoli N, Martinucci I, Savarino E, Franchi R, Bertani L, Russo S, Ceccarelli L, Costa F, Bellini M, Blandizzi C. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure. Dis Esophagus. 2014;Epub ahead of print. [PMID: 25212408 DOI: 10.1111/dote.12284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
114 Savarino E, Zentilin P, Marabotto E, Pellegatta G, Coppo C, Brunacci M, Dulbecco P, Savarino V. Drugs for improving esophageal mucosa defense: where are we now and where are we going? Ann Gastroenterol 2017;30:585-91. [PMID: 29118552 DOI: 10.20524/aog.2017.0187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
115 Ghisa M, Della Coletta M, Barbuscio I, Marabotto E, Barberio B, Frazzoni M, De Bortoli N, Zentilin P, Tolone S, Ottonello A, Lorenzon G, Savarino V, Savarino E. Updates in the field of non-esophageal gastroesophageal reflux disorder. Expert Rev Gastroenterol Hepatol 2019;13:827-38. [PMID: 31322443 DOI: 10.1080/17474124.2019.1645593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
116 Losa M, Manz SM, Schindler V, Savarino E, Pohl D. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease. Neurogastroenterol Motil 2021;33:e14177. [PMID: 34128293 DOI: 10.1111/nmo.14177] [Reference Citation Analysis]
117 Kahrilas PJ, Savarino E, Anastasiou F, Bredenoord AJ, Corsetti M, Lagergren J, Mendive J, Nelson S, Roman S, Zerbib F, Hungin P. The tapestry of reflux syndromes: translating new insight into clinical practice. Br J Gen Pract 2021;71:470-3. [PMID: 34593403 DOI: 10.3399/bjgp21X717329] [Reference Citation Analysis]
118 Kondo T, Oshima T, Tomita T, Fukui H, Okada H, Watari J, Miwa H. The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. Clin Gastroenterol Hepatol 2015;13:1249-1255.e1. [PMID: 25632805 DOI: 10.1016/j.cgh.2015.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
119 Hobbs P, Gyawali CP. The role of esophageal pH-impedance testing in clinical practice. Current Opinion in Gastroenterology 2018;34:249-57. [DOI: 10.1097/mog.0000000000000441] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
120 Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Tolone S, De Bortoli N, Frazzoni M, Savarino E. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. Expert Rev Clin Pharmacol 2020;13:437-49. [PMID: 32253948 DOI: 10.1080/17512433.2020.1752664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Savarino E, Zentilin P, Mastracci L, Fiocca R, Savarino V. Light microscopy is useful to better define NERD and functional heartburn. Gut 2014;63:368. [PMID: 24048735 DOI: 10.1136/gutjnl-2013-305955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
122 Cesario S, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Diagnosis of GERD in typical and atypical manifestations. Acta Biomed 2018;89:33-9. [PMID: 30561415 DOI: 10.23750/abm.v89i8-S.7963] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
123 Pandit S, Boktor M, Alexander JS, Becker F, Morris J. Gastroesophageal reflux disease: A clinical overview for primary care physicians. Pathophysiology. 2018;25:1-11. [PMID: 28943113 DOI: 10.1016/j.pathophys.2017.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
124 Ghisa M, Barberio B, Savarino V, Marabotto E, Ribolsi M, Bodini G, Zingone F, Frazzoni M, Savarino E. The Lyon Consensus: Does It Differ From the Previous Ones? J Neurogastroenterol Motil 2020;26:311-21. [PMID: 32606254 DOI: 10.5056/jnm20046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
125 Martinucci I, Savarino EV, Pandolfino JE, Russo S, Bellini M, Tolone S, Tutuian R, Roman S, Furnari M, Frazzoni M, Macchia L, Savarino V, Marchi S, de Bortoli N. Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD. Neurogastroenterol Motil 2016;28:243-50. [PMID: 26661383 DOI: 10.1111/nmo.12719] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
126 Furnari M, Zentilin P, Mastracci L, Savarino E. Esophageal biopsies in the management of GERD: complementary tool for many but not for all. Hum Pathol 2014;45:2512-3. [PMID: 25248575 DOI: 10.1016/j.humpath.2014.06.029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Zhang M, Chen M, Peng S, Xiao Y. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. United European Gastroenterol J 2018;6:358-66. [PMID: 29774149 DOI: 10.1177/2050640617735084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
128 Forootan M, Zojaji H, Ehsani MJ, Darvishi M. Advances in the Diagnosis of GERD Using the Esophageal pH Monitoring, Gastro-Esophageal Impedance-pH Monitoring, And Pitfalls. Open Access Maced J Med Sci 2018;6:1934-40. [PMID: 30455777 DOI: 10.3889/oamjms.2018.410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
129 de Bortoli N, Martinucci I, Marchi S, Savarino E. Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach. Surg Endosc 2014;28:698-9. [PMID: 23996339 DOI: 10.1007/s00464-013-3174-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 de Bortoli N, Martinucci I, Bertani L, Russo S, Franchi R, Furnari M, Tolone S, Bodini G, Bolognesi V, Bellini M, Savarino V, Marchi S, Savarino EV. Esophageal testing: What we have so far. World J Gastrointest Pathophysiol 2016; 7(1): 72-85 [PMID: 26909230 DOI: 10.4291/wjgp.v7.i1.72] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
131 Wasielica-Berger J, Kemona A, Kiśluk J, Świdnicka-Siergiejko A, Rogalski P, Chwieśko A, Kostrzewska M, Dąbrowski A. The added value of magnifying endoscopy in diagnosing patients with certain gastroesophageal reflux disease. Adv Med Sci 2018;63:359-66. [PMID: 30114679 DOI: 10.1016/j.advms.2018.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Savarino E, Zentilin P, Savarino V. Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol 2013;108:1657-8. [PMID: 24091511 DOI: 10.1038/ajg.2013.276] [Reference Citation Analysis]